Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


The systemic effect of type 1 interferon responsiveness on tumor immunotherapy

Immune checkpoint blocking therapies do not always work and come with some risks, but identifying non-responders and patients at risk of adverse events is becoming easier and more accurate.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Workflow for defining the outcome of PD-1 blockade therapy on T cell responsiveness to type I IFNs.


  1. Quesada, J. R. et al. N. Engl. J. Med. 310, 15–18 (1984).

    Article  CAS  Google Scholar 

  2. Zitvogel, L. et al. Nat. Rev. Immunol. 15, 405–414 (2015).

    Article  CAS  Google Scholar 

  3. Boukhaled, G. M. et al. Nat. Immunol. (2022).

    Article  PubMed  Google Scholar 

  4. Zhang, T. et al. MedComm 2, 618–653 (2021).

    Article  CAS  Google Scholar 

  5. Boukhaled, G. M., Harding, S. & Brooks, D. G. Annu. Rev. Pathol. 16, 167–198 (2021).

    Article  CAS  Google Scholar 

  6. Benci, J. L. et al. Cell 167, 1540–1554.e12 (2016).

    Article  CAS  Google Scholar 

  7. Liu, J. et al. Nat. Can. 2, 457–473 (2021).

    Article  CAS  Google Scholar 

  8. Bai, X. et al. Clin. Cancer Res. 27, 5993–6000 (2021).

    Article  CAS  Google Scholar 

  9. Nishino, M. et al. Nat. Rev. Clin. Oncol. 14, 655–668 (2017).

    Article  CAS  Google Scholar 

  10. Litchfield, K. et al. Cell 184, 596–614.e14 (2021).

    Article  CAS  Google Scholar 

  11. Zhang, J. et al. Trends Immunol. 55, 738–748 (2022).

    Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Erwei Song.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Su, S., Song, E. The systemic effect of type 1 interferon responsiveness on tumor immunotherapy. Nat Immunol 23, 1141–1143 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer